Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging.

[1]  P. Wen,et al.  Neurologic Complications of Cancer , 2003 .

[2]  S. Arnold,et al.  Diagnosis and management of brain metastases. , 2001, Hematology/oncology clinics of North America.

[3]  J. Mattiello,et al.  Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage , 2001, Neurology.

[4]  S. Pomeroy,et al.  Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies. , 2001, Pediatrics.

[5]  G. Barnett,et al.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery , 2001, International journal of cancer.

[6]  J. Gurney,et al.  Brain and other central nervous system tumors: rates, trends, and epidemiology , 2001, Current opinion in oncology.

[7]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[8]  C. Colosimo,et al.  Detection of Intracranial Metastases: A Multicenter, Intrapatient Comparison of Gadobenate Dimeglumine-Enhanced MRI with Routinely Used Contrast Agents at Equal Dosage , 2001, Investigative radiology.

[9]  F. Davis,et al.  Epidemiology of brain tumors. , 2000, Current opinion in neurology.

[10]  A. Markoe,et al.  Early MRI findings in High Grade Glioma , 2000, Journal of Neuro-Oncology.

[11]  D. Hoffmann,et al.  Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy--initial results. , 1999, Radiology.

[12]  P. Ricci.  Imaging of adult brain tumors. , 1999, Neuroimaging clinics of North America.

[13]  F. Davis,et al.  The descriptive epidemiology of brain tumors. , 1999, Neuroimaging clinics of North America.

[14]  Linet,et al.  RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. , 1999, Journal of the National Cancer Institute.

[15]  H. Newton,et al.  Clinical Presentation, Diagnosis, and Pharmacotherapy of Patients with Primary Brain Tumors , 1999, The Annals of pharmacotherapy.

[16]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[17]  P. V. van Rijk,et al.  Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study. , 1999, Nuclear medicine communications.

[18]  D. Hellwig,et al.  [Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)]. , 1999, Medizinische Klinik.

[19]  A. Field,et al.  Evaluation of the patient with nontraumatic headache: an evidence based approach. , 1999, Emergency medicine clinics of North America.

[20]  K. Skullerud,et al.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma , 1998, Journal of Neuro-Oncology.

[21]  B. Maria,et al.  Comparative value of thallium and glucose SPECT imaging in childhood brain tumors. , 1998, Pediatric neurology.

[22]  D. Andrews,et al.  Comparative assessment of four different Tl-201 tumor uptake indices in the evaluation of brain tumors. , 1998, Clinical nuclear medicine.

[23]  H. Harnsberger,et al.  Ultra high resolution nonenhanced fast spin echo magnetic resonance imaging: Cost-effective screening for acoustic neuroma in patients with sudden sensorineural hearing loss , 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  P. Corr,et al.  The value of 201thallium-SPECT imaging in childhood brainstem gliomas , 1998, Pediatric Radiology.

[25]  T. Yoshimoto,et al.  Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. , 1998, Neurologia medico-chirurgica.

[26]  D. Arnold,et al.  Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.

[27]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[28]  D. Aron,et al.  Management of incidental pituitary microadenomas: a cost-effectiveness analysis. , 1997, The Journal of clinical endocrinology and metabolism.

[29]  M. Hanson,et al.  Proposed Algorithm to Aid the Diagnosis of Cerebellopontine Angle Tumors , 1997, Southern medical journal.

[30]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 4-Analyzing the Model and Interpreting the Results , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 5—Working with Markov Processes , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 2—Building a Tree , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 1—Getting Started , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[34]  A S Detsky,et al.  Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[35]  P. Barnes,et al.  Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. , 1997, Radiology.

[36]  C. Mottolese,et al.  Brain metastases in children with solid tumors , 1997, Cancer.

[37]  B. Young,et al.  Demographics of brain metastasis. , 1996, Neurosurgery clinics of North America.

[38]  S. Preston‐Martin.  Epidemiology of primary CNS neoplasms. , 1996, Neurologic clinics.

[39]  D. Louw,et al.  Epidemiology of Childhood Brain Tumors , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[40]  J. Birkmeyer,et al.  Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. , 1995, Chest.

[41]  M. Orringer,et al.  Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. , 1995, AJNR. American journal of neuroradiology.

[42]  J Michaelis,et al.  Childhood malignancies in Germany--methods and results of a nationwide registry. , 1995, European journal of cancer.

[43]  Diana B. Petitti,et al.  Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .

[44]  M. Handrigan,et al.  Signs and symptoms of patients with brain tumors presenting to the emergency department. , 1993, The Journal of emergency medicine.

[45]  J. Henson,et al.  Extraneural metastases in ependymoma , 1992, Journal of Neuro-Oncology.

[46]  M. Blettner,et al.  Medical risk factors and the development of brain tumors , 1992, Cancer.

[47]  M. Rosenblum,et al.  Extraneural metastases of infratentorial glioblastoma multiforme to the peritoneal cavity , 1992, Cancer.

[48]  R. Mitnick,et al.  Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature. , 1991, Journal of neurosurgery.

[49]  R. Golfieri,et al.  [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis]. , 1991, La Radiologia medica.

[50]  J D Habbema,et al.  Analysing clinical decision analyses. , 1990, Statistics in medicine.

[51]  A. Detsky,et al.  A clinician's guide to cost-effectiveness analysis. , 1990, Annals of internal medicine.

[52]  L. Heier,et al.  Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. , 1990, AJNR. American journal of neuroradiology.

[53]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[54]  C. Mettlin,et al.  National survey of patterns of care for brain-tumor patients. , 1989, Journal of neurosurgery.

[55]  J. Eisenberg,et al.  Clinical Economics: A Guide to the Economic Analysis of Clinical Practices , 1989 .

[56]  J. van Nagell,et al.  Neurologic complications of cervical cancer. A review of 2261 cases , 1989, Cancer.

[57]  G. Krol,et al.  Distribution of brain metastases. , 1988, Archives of neurology.

[58]  J. Bentson,et al.  Diagnostic Imaging in Clinical Cancer Management: Brain Metastases , 1988, Investigative radiology.

[59]  G. Rutherfoord,et al.  Malignant glioma following radiotherapy for unrelated primary tumors , 1986, Cancer.

[60]  J. R. Hall,et al.  Fire experience in health care facilities. , 1986, The New England journal of medicine.

[61]  A. Walker,et al.  Epidemiology of brain tumors , 1985, Neurology.

[62]  C. Karakousis,et al.  Malignant melanoma brain metastases. Review of roswell park memorial institute experience , 1984, Cancer.

[63]  R. Cipolle,et al.  Value of computed tomographic scan in the evaluation of adult patients after their first seizure , 1984, Annals of neurology.

[64]  F. Graus,et al.  Brain metastases in children. , 1983, The Journal of pediatrics.

[65]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[66]  G. Omenn,et al.  Diagnostic evaluation of headache. Impact of computerized tomography and cost-effectiveness. , 1980, JAMA.

[67]  A. Piazza,et al.  Analysis of Some Factors Effecting Survival in Malignant Gliomas , 1979, Tumori.

[68]  V. Vaitkevicius,et al.  Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival , 1978, Cancer.

[69]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[70]  R. Vannucci,et al.  Cerebral metastatic disease in childhood , 1974, Neurology.

[71]  E. Taşdemiroğlu,et al.  Cerebral metastases in childhood malignancies , 2005, Acta Neurochirurgica.

[72]  R. Eda,et al.  Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma. , 1999, Oncology reports.

[73]  S. Brem,et al.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.

[74]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[75]  H. Newton.  Primary brain tumors: review of etiology, diagnosis and treatment. , 1994, American family physician.

[76]  J. Posner,et al.  Management of brain metastases. , 1992, Revue neurologique.

[77]  E. Silverberg,et al.  Cancer statistics, 1986 , 1986, CA: a cancer journal for clinicians.

[78]  Baker Hl.  Cranial CT in the investigation of headache: cost-effectiveness for brain tumors. , 1983 .

[79]  A. R. de Mello,et al.  [METASTATIC TUMORS OF THE CENTRAL NERVOUS SYSTEM]. , 1963, Jornal brasileiro de neurologia.

[80]  O. V. Batson.  THE RÔLE OF THE VERTEBRAL VEINS IN METASTATIC PROCESSES , 1942 .